HOME >> MEDICINE >> NEWS
Data announced at ISHLT: Molecular testing proves effective in monitoring heart transplant rejection

Breakthrough research presented today at the International Society for Heart and Lung Transplantation (ISHLT) 24th Annual Meeting in San Francisco could revolutionize the management of heart transplant patients.

The prospective, multi-center trial was designed to evaluate the clinical usefulness of a multi-gene molecular expression assay test developed to identify the "quiescent" state after heart transplantation and to determine the assay's ability to predict clinical outcomes. A major challenge physicians face in managing transplant patients is finding the right balance of drug therapy one that suppresses the patient's immune response enough to prevent rejection of the transplanted organ, but not so much that the immune system no longer competently fights infection and cancer. With this balance reached, the immune system is "quiescent."

Analysis from the eight-center trial revealed molecular testing using peripheral leukocyte gene expression can identify the quiescent state and predict future occurrence of rejection during the first year after cardiac transplantation.

"The development of alternative, non-invasive procedures, such as gene expression-based monitoring of the immune response, may provide us with the ability to predict organ rejection and provide better post-operative care," said Mandeep Mehra, M.D. and lead investigator for the study.

"This technology has many benefits. It can be used to identify patients with acute rejection early when it is most treatable, help us better manage patients' immunosuppression regimens and provide a means to resolve uncertainties of a biopsy."

For patients, the test could mean less discomfort during the constant monitoring for rejection and prolonged transplant success. Worldwide, approximately 4,500 cardiac transplants are performed annually. The most common cause of death in the first year after transplantation is acute cardiac rejection
'"/>

Contact: Kelly Goff
kellygoff@server63.com
210-378-1980
International Society for Heart and Lung Transplantation
23-Apr-2004


Page: 1 2

Related medicine news :

1. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
2. Innovation prize finalists announced in Science of Better
3. 2004 Science-in-Society Award winners announced
4. National Academies news: Communication Awards winners announced
5. AIUM announced education and research grant recipients at the 2004 AIUM Annual Convention
6. Paper of the year winner announced
7. 2003 winners of Collegiate Inventors Competition announced in NYC
8. Professorial Fellowships announced
9. Exanta - pivitol data from largest ever phase III stroke prevention trial announced at ACC
10. Treatment guidelines for HIV infection announced by international panel of AIDS experts
11. 2002-2003 AARP Andrus Foundation scholarship-fellowship program awardees announced

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/29/2020)... MONTREAL (PRWEB) , ... August 29, 2020 , ... When ... - perhaps with greater ease than most people would. Rather than become melancholic, however, ... yet deep advice on achieving one’s dreams. Randy Pausch took a negative situation and ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , Hespiro™ is ... with respiratory conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. ... exhaled gas and scrubs it free of carbon dioxide in a completely closed ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... Nourished Group set out to continue helping the specialty-diet community connect with ... new gluten-free products, get coupons, enter giveaways, chat with brands & watch over ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... Adventist Health on its investment in Synchronous Health, a tech-enabled behavioral health and ... the strength of human empathy with artificial intelligence (AI) to increase access and ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Using Analysis of Variance ... Thursday, Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/anova , How much ... , While one can’t become one in 90 minutes, one can master a ...
(Date:9/2/2020)... ... September 02, 2020 , ... ... Covid-19 , Advanced Penetration Technology, LLC, (APT) a Texas- and Indiana-based company ... non-prescription, Over The Counter (OTC) products, was today provided results of an ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... Cosmetics and Laser Surgery at the University of Rochester Medical Center, in Upstate ... SkinCare Physicians in Boston, with clinical faculty from the Harvard and Yale Departments ...
Breaking Medicine Technology:
Cached News: